Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Fullerene as a transporter for doxorubicin investigated by analytical methods and in vivo imaging.

Blazkova I, Viet Nguyen H, Kominkova M, Konecna R, Chudobova D, Krejcova L, Kopel P, Hynek D, Zitka O, Beklova M, Adam V, Kizek R.

Electrophoresis. 2014 Apr;35(7):1040-9. doi: 10.1002/elps.201300393. Epub 2014 Jan 13.

PMID:
24254731
2.

Fullerene-conjugated doxorubicin in cells.

Liu JH, Cao L, Luo PG, Yang ST, Lu F, Wang H, Meziani MJ, Haque SA, Liu Y, Lacher S, Sun YP.

ACS Appl Mater Interfaces. 2010 May;2(5):1384-9. doi: 10.1021/am100037y.

PMID:
20420365
3.

Interaction of C60 fullerene complexed to doxorubicin with model bilipid membranes and its uptake by HeLa cells.

Prylutskyy Y, Bychko A, Sokolova V, Prylutska S, Evstigneev M, Rybalchenko V, Epple M, Scharff P.

Mater Sci Eng C Mater Biol Appl. 2016 Feb;59:398-403. doi: 10.1016/j.msec.2015.10.049. Epub 2015 Oct 19.

PMID:
26652389
4.

C60 fullerene prevents genotoxic effects of doxorubicin in human lymphocytes in vitro.

Afanasieva KS, Prylutska SV, Lozovik AV, Bogutska KI, Sivolob AV, Prylutskyy YI, Ritter U, Scharff P.

Ukr Biochem J. 2015 Jan-Feb;87(1):91-8.

PMID:
26036135
5.

Characterization of C60 fullerene complexation with antibiotic doxorubicin.

Prylutskyy YI, Evstigneev MP, Pashkova IS, Wyrzykowski D, Woziwodzka A, Gołuński G, Piosik J, Cherepanov VV, Ritter U.

Phys Chem Chem Phys. 2014 Nov 14;16(42):23164-72. doi: 10.1039/c4cp03367a.

PMID:
25251969
6.

Characterization and anti-tumor activity of chemical conjugation of doxorubicin in polymeric micelles (DOX-P) in vitro.

Zhao YZ, Sun CZ, Lu CT, Dai DD, Lv HF, Wu Y, Wan CW, Chen LJ, Lin M, Li XK.

Cancer Lett. 2011 Dec 8;311(2):187-94. doi: 10.1016/j.canlet.2011.07.013. Epub 2011 Aug 5.

PMID:
21872982
7.

Application of C60 Fullerene-Doxorubicin Complex for Tumor Cell Treatment In Vitro and In Vivo.

Panchuk RR, Prylutska SV, Chumakl VV, Skorokhyd NR, Lehka LV, Evstigneev MP, Prylutskyy YI, Berger W, Heffeter P, Scharff P, Ritter U, Stoika RS.

J Biomed Nanotechnol. 2015 Jul;11(7):1139-52.

PMID:
26307837
8.

Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.

Qiu LY, Yan L, Zhang L, Jin YM, Zhao QH.

Int J Pharm. 2013 Nov 18;456(2):315-24. doi: 10.1016/j.ijpharm.2013.08.071. Epub 2013 Sep 7.

PMID:
24016742
9.

Polyanionic carbohydrate doxorubicin-dextran nanocomplex as a delivery system for anticancer drugs: in vitro analysis and evaluations.

Yousefpour P, Atyabi F, Farahani EV, Sakhtianchi R, Dinarvand R.

Int J Nanomedicine. 2011;6:1487-96. doi: 10.2147/IJN.S18535. Epub 2011 Jul 11.

10.

Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery.

Scomparin A, Salmaso S, Bersani S, Satchi-Fainaro R, Caliceti P.

Eur J Pharm Sci. 2011 Apr 18;42(5):547-58. doi: 10.1016/j.ejps.2011.02.012. Epub 2011 Mar 1.

PMID:
21371555
11.

PEGylated PAMAM dendrimer-doxorubicin conjugates: in vitro evaluation and in vivo tumor accumulation.

Zhu S, Hong M, Zhang L, Tang G, Jiang Y, Pei Y.

Pharm Res. 2010 Jan;27(1):161-74. doi: 10.1007/s11095-009-9992-1. Epub 2009 Oct 28.

PMID:
19862607
12.

Development, characterization and cancer targeting potential of surface engineered carbon nanotubes.

Mehra NK, Jain NK.

J Drug Target. 2013 Sep;21(8):745-58. doi: 10.3109/1061186X.2013.813028. Epub 2013 Jul 4.

PMID:
23822734
13.
14.

Delivery of hydrophilic drug doxorubicin hydrochloride-targeted liver using apoAI as carrier.

Yuan Y, Wang W, Wang B, Zhu H, Zhang B, Feng M.

J Drug Target. 2013 May;21(4):367-74. doi: 10.3109/1061186X.2012.757769. Epub 2013 Apr 19.

PMID:
23600747
15.

Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging.

Yang X, Grailer JJ, Rowland IJ, Javadi A, Hurley SA, Matson VZ, Steeber DA, Gong S.

ACS Nano. 2010 Nov 23;4(11):6805-17. doi: 10.1021/nn101670k. Epub 2010 Oct 19.

PMID:
20958084
16.

Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.

Sahoo B, Devi KS, Banerjee R, Maiti TK, Pramanik P, Dhara D.

ACS Appl Mater Interfaces. 2013 May;5(9):3884-93. doi: 10.1021/am400572b. Epub 2013 Apr 23.

PMID:
23551195
17.

Water-dispersible fullerene aggregates as a targeted anticancer prodrug with both chemo- and photodynamic therapeutic actions.

Fan J, Fang G, Zeng F, Wang X, Wu S.

Small. 2013 Feb 25;9(4):613-21. doi: 10.1002/smll.201201456. Epub 2012 Nov 1.

PMID:
23117954
18.

Oxidized phospholipid based pH sensitive micelles for delivery of anthracyclines to resistant leukemia cells in vitro.

Wang Y, Chen L, Ding Y, Yan W.

Int J Pharm. 2012 Jan 17;422(1-2):409-17. doi: 10.1016/j.ijpharm.2011.10.029. Epub 2011 Oct 20.

PMID:
22037443
19.

[60]Fullerene-peptides: bio-nano conjugates with structural and chemical diversity.

Barron AR.

J Enzyme Inhib Med Chem. 2016;31(sup1):164-176. Epub 2016 May 10. Review.

PMID:
27168130
20.

Novel water-soluble and pH-responsive anticancer drug nanocarriers: doxorubicin-PAMAM dendrimer conjugates attached to superparamagnetic iron oxide nanoparticles (IONPs).

Chang Y, Meng X, Zhao Y, Li K, Zhao B, Zhu M, Li Y, Chen X, Wang J.

J Colloid Interface Sci. 2011 Nov 1;363(1):403-9. doi: 10.1016/j.jcis.2011.06.086. Epub 2011 Jul 23.

PMID:
21821262

Supplemental Content

Support Center